78.28000 USD
2.2
2.73%
Last update Dec 16, 3:59 PM EST
Market closed
Day range
77.68500
81.074997
Previous close
80.48000
Open
80.099998
Access this stock data via API
Subscribe
Tarsus Pharmaceuticals Inc.
78.28
2.20
2.73%

Financials

Income statement

Fiscal date Sep 2025 Jun 2025 Mar 2025 Dec 2024
Total reported revenue 118.7M 102.7M 78.3M 66.4M
Cost of revenue 8.3M 6.2M 5.2M 4.9M
Gross profit 110.4M 96.4M 73.1M 61.5M
Operating expense
Research & development 16.3M 15.6M 14.4M 16.9M
Selling general and admin 108.6M 103.0M 85.0M 69.0M
Other operating expenses
Operating income -14.5M -22.2M -26.3M -24.4M
Non operating interest income
Income 4.1M 4.2M 3.5M 3.6M
Expense 2.1M 2.1M 2.1M 2.2M
Other income expense 98K -145K -81K -27K
Pretax income -12.6M -20.3M -25.1M -23.1M
Tax provision
Net income -12.6M -20.3M -25.1M -23.1M
Basic EPS -0.3 -0.5 -0.6 -0.6
Diluted EPS -0.3 -0.5 -0.6 -0.6
Basic average shares 42.6M 42.4M 39.3M 38.6M
Diluted average shares 42.6M 42.4M 39.3M 38.6M
EBITDA -10.0M -17.8M -22.6M -20.5M
Net income from continuing op. -12.6M -20.3M -25.1M -23.1M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 6 hours 28 minutes

21:31
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).